查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363953

2023-2030年全球自动免疫分析仪市场

Global Automatic Immunoassay Analyzer Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 200 Pages | 商品交期: 2-3个工作天内

价格

预计在预测期内（2023-2030），全球自动免疫分析仪市场将以 14.8% 的复合年增长率成长。自动免疫分析仪是用于免疫分析测试的医疗设备类型，有助于检测特定血液样本中存在的蛋白质分析。由于它们在发布测试方面的优势和操作的准确性，它们的使用正在不断增长。用于诊断和检测微生物感染的免疫测定需求的增长是预计推动免疫测定分析仪市场成长和需求的重要因素之一。

细分市场前景

全球自动免疫分析仪市场按应用和产品细分。根据应用，市场细分为传染病、内分泌、药物监测、慢性病和过敏检测。根据产品，市场细分为免疫萤光、化学发光、酵素连结萤光系统和放射免疫分析。其中，慢性病细分市场预计将占据相当大的市场份额，因为糖尿病、心血管疾病、癌症和传染病等慢性病的盛行率不断上升，推动了对免疫分析等诊断工具的需求分析仪。

预计传染病细分市场将在全球自动免疫分析仪市场中占据相当大的份额

其中，传染病细分领域预计将在全球自动免疫分析仪市场中占据相当大的份额。此细分市场的成长归因于传染患者病率的增加是推动自动免疫分析仪市场成长的传统关键因素之一。及早发现传染病对于减少身体受到严重损害的可能性非常重要。因此，在最短的时间内对肝炎、流感、性传染病和许多其他感染等感染进行适当和准确的筛检预计将成为主要的市场成长因素。因此，该公司正在专注于引入新的、先进的自动化解决方案，以实现更好的筛选。例如，2023 年7 月，Beckman Coulter Diagnostics 的新型DxC 500 AU 化学分析仪（一种自动化化学分析仪）获得FDA 批准，扩大了公司的临床化学产品范围，并展示了对体外诊断行业产品创新的持续承诺。 DxC 500 AU 化学分析仪专为中小型实验室设计，是 Beckman Coulter 最新推出的几款解决方案之一，旨在优化实验室工作流程并支援关键的临床决策。

区域展望

全球自动免疫分析仪市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，由于技术的快速发展和免疫分析测试在各种应用中的使用量的增加，预计亚太地区将在全球市场中占据显着份额。例如，2023年4月，中国公司Fapon Biotech Inc.宣布了其创新的化学发光一站式解决方案策略。法蓬化学发光一站式解决方案旨在提供全系列化学发光产品和服务，包括不同等级的全自动化学发光分析仪、开放系统平台、试剂开发支援以及大量生产的高品质核心原料。 Fapon Biotech旨在帮助当地体外诊断（IVD）合作伙伴快速扩展其产品组合併简化其生产流程，并加速其在化学发光免疫分析行业的业务。

北美地区预计全球自动免疫分析仪市场复合年增长率显着成长

在所有地区中，北美地区预计在预测期内将以相当大的复合年增长率成长。区域成长归因于老年人口的增加和生活方式的快速变化。相应地，由于医疗产品的容易取得以及先进的技术以及医疗保健中自动化产品的高采用率。例如，2023 年 1 月，Qiagen 推出了 EZ2 Connect MDx IVD 平台，用于诊断实验室的自动采样。该公司在该平台可供研究 18 个月后提供广泛使用。 EZ2 Connect MDx 设备自动化程度高，使实验室能够在 30 分钟内对多达 24 个样本进行 DNA 和 RNA 的平行纯化。该平台在加拿大、美国和其他国家/地区提供，具有欧盟 CE-IVD 体外器械 (IVD) 合规标誌，适用于欧盟和其他接受此指定的国家。

因此，该国在采用自动免疫分析仪生产方面发生了重大转变。由于医疗设备的趋势变化和进步，预计将继续支持该地区市场收入成长的其他关键因素。例如，2023 年 7 月，贝克曼库尔特在北美首次推出了 DxI 9000 Access 免疫分析仪，满足临床实验室对速度、可靠性、重现性、品质和菜单扩展的需求。 DxI 9000 分析仪已显示出开发日益敏感和临床相关检测的能力，使该平台能够跟上未来的测试要求，因为医疗保健提供者和製药公司致力于应对更具挑战性的疾病。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Abbott Laboratories
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Carolina Liquid Chemistries Corp
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • F. Hoffmann-La Roche AG
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 全球自动免疫分析仪市场（按应用）
    • 传染性疾病
    • 内分泌科
    • 药物监测
    • 慢性疾病
    • 过敏测试
  • 全球自动免疫分析仪市场（按产品）
    • 免疫萤光
    • 化学发光
    • 酵素连结萤光系统
    • 放射免疫分析法

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • Aesku Diagnotics
  • Arlington Scientific
  • Becton Dickinson and Company
  • Biokit S.A
  • BioMerieux
  • BioRad Laboratories
  • Inova DX
  • Luminex Corporation
  • Meril Life Sciences
  • Ortho Clinical Diagnostics
  • Perkin Elmer
  • Randox Laboratories
  • Siemens Healthcare
Product Code: OMR2027717

Title: Global Automatic Immunoassay Analyzer Market Size, Share & Trends Analysis Report by Application (Infectious Diseases, Endocrinology, Drug Monitoring, Chronic Diseases, and Allergy Testing), and by Product (Immunofluorescence, Chemiluminescence, Enzyme Linked Fluorescent System, and Radioimmunoassay)Forecast Period (2023-2030).

The global Automatic Immunoassay Analyzer market is anticipated to grow at a CAGR of 14.8% during the forecast period (2023-2030). Automatic Immunoassay analyzers are the type of medical devices that are used for the immunoassay test which helps in the detection of protein analyze present in a specific blood sample. Their usage is growing owing to their benefits in publishing tests and the accurateness of their operations. The rise in demand for immunoassay to diagnose and detect microorganism-based infections is amongst the significant factors expected to fuel the growth and demand of immunoassay analyzers market.

Segmental Outlook

The global Automatic Immunoassay Analyzer market is segmented on the Application and product. Based on the application, the market is sub-segmented into infectious diseases, endocrinology, drug monitoring, chronic diseases, and allergy testing. based on the product, the market is sub-segmented into immunofluorescence, chemiluminescence, enzyme linked fluorescent system, and radioimmunoassay. Among the application, the Chronic Diseases sub-segment is anticipated to hold a considerable share of the market, owing to the increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, cancer, and infectious diseases has driven the demand for diagnostic tools like immunoassay analyzers.

The Infectious diseases Sub-Segment is Anticipated to Hold a Considerable Share of the Global Automatic Immunoassay Analyzer Market

Among the application, the infectious diseases sub-segment is expected to hold a considerable share of the global automatic immunoassay analyzer market. The segmental growth is attributed to Increasing prevalence of infectious diseases is one of the crucial factors that is conventional to drive automated immunoassay analyzers market growth. Early detection of infectious diseases is important to reduce the possibility of severe damage to the body. Thus, proper and accurate screening of infections such as Hepatitis, influenza, STDs, and numerous other infections in minimal time is projected to be a major market growth factor. Hence companies are focusing on introducing new and advanced automatic solution for better screening. For an instance, in July 2023, Beckman Coulter Diagnostics, received FDA clearance for its new DxC 500 AU Chemistry Analyzer, an automated chemistry analyzer, expanding the company's clinical chemistry offering and demonstrating ongoing commitment to product innovation in the in vitro diagnostic industry. Designed for small-to-medium-sized laboratories, the DxC 500 AU Chemistry Analyzer is one of several recent Beckman Coulter solutions designed to optimize laboratory workflows and support critical clinical decisions.

Regional Outlook

The global automatic immunoassay analyzer market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing the rapid technological developments and increase in usage of immunoassay testing for various applications. For instance, in April 2023, Chinese firm Fapon Biotech Inc. announced its innovative chemiluminescence one-stop solution strategy. Fapon chemiluminescence one-stop solution is designed to provide a complete range of chemiluminescence products and services, consisting of different levels of fully automatic chemiluminescence analysers with open system platforms, reagent development support, as well as high quality core raw material in bulk production. Fapon Biotech aims to help local in-vitro diagnostic (IVD) partners quickly extend their product portfolio and streamline their production processes, as well as accelerate their business in the chemiluminescence immunoassay industry.

The North America Region is Expected to Grow at a Significant CAGR in the Global Automatic Immunoassay Analyzer Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising in Geriatric Population and Rapid Change in Lifestyle. Correspondingly owing to easy availability of medical products along with advanced technologies and the high adoption rate of the automatic products in healthcare. For an instance, in January 2023, Qiagen has launched the EZ2 Connect MDx IVD platform for automated sampling in diagnostic laboratories. The company is offering the platform for widescale use 18 months after it was made available for research. The EZ2 Connect MDx device has a high degree of automation and enables laboratories to perform parallel purification of DNA and RNA from up to 24 samples in 30 minutes. Available in Canada, the US and other countries, the platform has EU CE-IVD compliance marking for in-vitro devices (IVD) for the European Union and other countries accepting this designation.

Hence, there is considerable shift of the country towards the adoption of the Automatic Immunoassay Analyzer production. Owing to changing trends and advancements in Medical Devices are other key factors expected to continue to support market revenue growth in the region. For an instance, in July 2023, Beckman Coulter, revealed for the first time in North America the DxI 9000 Access Immunoassay Analyzer, addressing clinical laboratory demands for speed, reliability, reproducibility, quality, and menu expansion. The DxI 9000 Analyzer has shown capability to develop increasingly sensitive and clinically relevant assays enabling the platform to keep pace with tomorrow's testing requirements as healthcare providers and pharmaceutical companies take aim at evermore challenging diseases.

Market Players Outlook

The major companies serving the global automatic immunoassay analyzer market include F. Hoffmann-La Roche Ltd., Abbott, BD, Beckman Coulter, Inc., Ortho Clinical Diagnostics, bioMerieux SA, Biokit S.A, The Binding Site Group Ltd., Quidel Corporation, Immunodiagnostic Systems, Merck KGaA, Olympus Corporation, Nova Century Scientific, Inc., Luminex Corporation, DiaSorin S.p.A., Bio-Rad Laboratories, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in February 2023, Agilent Technologies Inc. announced their xCELLigence RTCA HT (real-time cell analysis high-throughput) platform which integrates with the BioTek BioSpa 8 Automated Incubator. Developed in response to market needs, this combination enables a higher level of workflow automation that provides novel functionality for the development of label-free high-throughput potency assays for the immuno-oncology space and high-throughput viral cytopathic effects (CPE) assays for the vaccine market.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global automatic immunoassay analyzer market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Carolina Liquid Chemistries Corp
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. F. Hoffmann-La Roche AG
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Automatic Immunoassay Analyzer Market by Application
    • 4.1.1. Infectious Diseases
    • 4.1.2. Endocrinology
    • 4.1.3. Drug Monitoring
    • 4.1.4. Chronic Diseases
    • 4.1.5. Allergy Testing
  • 4.2. Global Automatic Immunoassay Analyzer Market by Product
    • 4.2.1. Immunofluorescence
    • 4.2.2. Chemiluminescence
    • 4.2.3. Enzyme Linked Fluorescent System
    • 4.2.4. Radioimmunoassay

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Aesku Diagnotics
  • 6.2. Arlington Scientific
  • 6.3. Becton Dickinson and Company
  • 6.4. Biokit S.A
  • 6.5. BioMerieux
  • 6.6. BioRad Laboratories
  • 6.7. Inova DX
  • 6.8. Luminex Corporation
  • 6.9. Meril Life Sciences
  • 6.10. Ortho Clinical Diagnostics
  • 6.11. Perkin Elmer
  • 6.12. Randox Laboratories
  • 6.13. Siemens Healthcare

LIST OF TABLES

  • 1. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 2. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR ENDOCRINOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR DRUG MONITORING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR CHRONIC DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR ALLERGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 8. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN IMMUNOFLUORESCENCE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN CHEMILUMINESCENCE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN ENZYME LINKED FLUORESCENT SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN RADIOIMMUNOASSAY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 16. EUROPEAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. EUROPEAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 18. EUROPEAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 19. ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 21. ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 22. REST OF THE WORLD AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. REST OF THE WORLD AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 24. REST OF THE WORLD AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 2. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR INFECTIOUS DISEASES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR ENDOCRINOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR DRUG MONITORING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR CHRONIC DISEASES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR ALLERGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022 VS 2030 (%)
  • 8. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN IMMUNOFLUORESCENCE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN CHEMILUMINESCENCE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN ENZYME LINKED FLUORESCENT SYSTEM MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN RADIOIMMUNOASSAY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. US AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. CANADA AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. UK AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. FRANCE AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. GERMANY AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. ITALY AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. SPAIN AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. REST OF EUROPE AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. INDIA AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. CHINA AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. JAPAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. SOUTH KOREA AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)